公司概覽
業務類別 --
業務概覽 Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority ofthe company's revenue is generated from its injectables segment, which supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue-generating market, followed by the Middle East and North Africa, the United Kingdom, Europe, and the rest of the world.
公司地址 10 Portman Square, London, GBR, W1H 6AZ
電話號碼 +44 2073992760
傳真號碼 +44 2073992761
公司網頁 https://www.hikma.com
員工數量 9400
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Mazen Samih Taleb Darwazah Executive Director,Vice Chairman 美元 806.79K 23/04/2026
Mr. Said Darwazah Executive Director,Chief Executive Officer 美元 1.02M 06/08/2026
Mr. Henry J Knowles General Counsel -- 16/03/2023
Mr. Helen Middlemist Company Secretary -- 07/08/2026
Mr. Khalid Walid Hussni Nabilsi Executive Director -- 23/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Mazen Samih Taleb Darwazah Executive Director,Vice Chairman 23/04/2026
Ms. Victoria Mary Hull Non-Executive Director,Chairman 23/04/2026
Mr. Mohammed Ali Khaldoun S Al-Husry Non-Executive Director 23/04/2026
Mr. Douglas Michael Hurt Non-Executive Director,Senior Independent Director 23/04/2026
Mr. Said Darwazah Executive Director,Chief Executive Officer 06/08/2026
Ms. Cynthia L. Flowers Non-Executive Director 23/04/2026
Dr. Deneen Vojta, M.D. Non-Executive Director 23/04/2026
Mr. Tobias Hestler Non-Executive Director 07/08/2026
Ms. Laura Balan Non-Executive Director 23/04/2026
Mr. Khalid Walid Hussni Nabilsi Executive Director 23/04/2026
 
所屬ETF (更新日期: 19/09/2026 03:20)
代號 名稱 佔比% ▼ 持有日期
GMOIGMO International Value ETF0.02%31/08/2026
IGROiShares International Dividend Gr ETF0.02%31/08/2026
ICPYTweedy, Browne International Ins+Val ETF0.02%31/08/2026
VSGXVanguard ESG International Stock ETF0.01%31/08/2026
PDNInvesco RAFI Developed Mkts ex-US S-METF0.01%31/08/2026
AVDSAvantis International Small Cp Eq ETF0.01%31/08/2026
IEUSiShares MSCI Europe Small-Cap ETF0.01%31/08/2026
EWUSiShares MSCI United Kingdom Small-Cp ETF0.01%31/08/2026
WSMLiShares MSCI World Small-Cap ETF0.005%31/08/2026
MFDXPIMCO RAFI Dyn Multi-Factor Intl Eq ETF0.004%31/08/2026
SPEUState Street® SPDR® Portfolio Europe ETF0.003%31/08/2026
DFSIDimensional International Sstby Cr 1 ETF0.003%31/08/2026
DXIVDimensional International Vector Eq ETF0.002%31/08/2026
TLTDNorthern Trust MstarDevMktsexUSFacTltETF0.001%31/08/2026
TISCThrivent International Small Cap ETF0.001%31/07/2026
AVSDAvantis Responsible International Eq ETF0.001%31/08/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0002%31/08/2026
PBDMInvesco PureBeta FTSE Dev ex-NrthAmr ETF0.00003%31/05/2023
ACWIiShares MSCI ACWI ETF<0.000001%04/03/2026
ACWXiShares MSCI ACWI ex US ETF<0.000001%28/02/2026
  1   2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.